Sex-specific differences in metabolic outcomes after sleeve gastrectomy and intermittent fasting in obese middle-aged

Ana B Emiliano1, Natalie R Lopatinsky1, Marko Kraljević1,2

  • 1Columbia University Medical Center, New York, New York.

Insights

Middle-aged obese females show better metabolic outcomes than males after weight loss surgery or intermittent fasting. Intermittent fasting improves glucose tolerance in both sexes, regardless of weight loss.

Area of Science:

  • Metabolic research
  • Obesity therapeutics
  • Sex differences in physiology

Background:

  • Obesity is highly prevalent in middle-aged individuals.
  • The impact of sex differences on obesity treatment outcomes in middle age is not well understood.
  • Current obesity therapies may have variable efficacy based on sex.

Purpose of the Study:

  • To investigate sex differences in metabolic outcomes following obesity therapies in middle-aged mice.
  • To compare the effects of sleeve gastrectomy (SG) and intermittent fasting with calorie restriction (SH-IF) versus sham surgery (SH-AL).
  • To assess energy and glucose homeostasis parameters in response to different interventions.

Main Methods:

  • Middle-aged obese male and female mice were randomized into three groups: SG, SH-AL, or SH-IF.
  • Metabolic assessments included energy intake, body weight, energy expenditure, glucose and insulin tolerance tests.
  • Interscapular brown adipose tissue (iBAT) sympathetic innervation density was quantified.

Main Results:

  • Both SG and SH-IF female mice exhibited superior metabolic outcomes compared to males.
  • Females showed better weight loss maintenance, preserved fat-free mass (FFM), higher total energy expenditure (TEE), and reduced inflammatory markers.
  • Intermittent fasting improved glucose tolerance in both sexes, and females demonstrated increased iBAT sympathetic nerve density.

Conclusions:

  • Female sex is associated with enhanced metabolic benefits from sleeve gastrectomy or intermittent fasting in middle-aged obese mice.
  • Intermittent fasting effectively improves glucose homeostasis and prevents metabolic adaptation, even with FFM loss.
  • Further clinical studies are warranted to determine if sex should guide obesity therapy selection.